Whitfield Roy A reported grant involving 4,000 derivative units of NEKTAR THERAPEUTICS at $0.00 for $0 on Sep 23, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Sep 25, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
4,000Stock Option
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
4,000Direct
Trade date
Sep 23, 2026Grant
Filed
Sep 25, 2026, 8:29 PM ET3-day reporting delay
Accession
0001193125-26-403105Code A · Transaction 230053
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 23, 2026Grant2,000$0.00$0Trade 230052
2 transaction rows in this filing. Joint filers share the same rows.

NKTR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NKTR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.8%1w ago +0.4%1d ago 0%
Returns since7d −35%30d −45%90d180d1y

Footnotes in full

F1: Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2: This RSU award vests in full, one year following September 23, 2026. F3: On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. F4: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.